Remote Alcohol Use Research Study

Researchers at the University of Florida are conducting a remote study to learn more about alcohol use and sexual behavior in individuals who are at an increased risk of HIV infection. Remote appointments will be conducted through a site at Northeastern University.

Fast Facts

MSM assigned male at birth ages 18-30

Drink Alcohol Frequently

Compensation Provided

Remote Appointments via Zoom

Study Background

Researchers at Northeastern University have partnered with the University of Florida to develop a mobile intervention that aims to reduce drinking and improve sexual health behavior to prevent HIV infection. 

This program features a unique combination of interventions including:

  • Motivational intervention
  • Daily monitoring with personalized feedback
  • Pre-exposure prophylaxis (PrEP)
 
Principal Investigator: Robert Cook

Study Background

Researchers at Northeastern University have partnered with the University of Florida to develop a mobile intervention that aims to reduce drinking and improve sexual health behavior to prevent HIV infection. 

This program features a unique combination of interventions including:

  • Motivational intervention
  • Daily monitoring with personalized feedback
  • Pre-exposure prophylaxis (PrEP)

 

Principal Investigator: Robert Cook

Additional Information

Researchers at Northeastern University and the University of Florida are developing a mobile intervention that aims to reduce drinking and improve sexual health behaviors to prevent HIV infection.

You may qualify if you meet the following criteria.

Inclusion Criteria:

  • Assigned male at birth ages 18-30
  • Frequent alcohol consumption
  • Engaging in sexual intercourse with other males
  • HIV negative
  • Currently taking or willing to take PrEP
  • Able to speak, read, and write in English
  • Not using medications that interfere with PrEP (e.g., diuretics, nephrotoxic drugs, non-steroidal anti-inflammatory drugs, antiretroviral drugs)
  • No active hepatitis B infection

Over the course of this 6-month program, participants will attend remote study sessions including:

  • Initial screening and consent
  • In-person medical screening at the clinic of your choice if you have not attended one in the past 3 months
  • Training on the mobile intervention
  • Blood draw at 30 days to assess medication levels
  • 6-month in-person follow up at the PrEP clinic of your choice, as well as brief virtual follow-up appointment with study staff

Participants will be compensated on a pro-rated basis for each portion of the study that they complete. Compensation is up to $400 in the course of study participation.